0

Heart Failure Collection
 81-100 of 203 Articles
Articles |  1 August 1986
Sodium and Water Excretion Abnormalities in Congestive Heart Failure: Determinant Factors and Clinical Implications
BERTRAND METTAUER, M.D.; JEAN-LUCIEN ROULEAU, M.D.; DANIEL BICHET, M.D.; et al.
Ann Intern Med. 1986;105(2):161-167. doi:10.7326/0003-4819-105-2-161
Editorials |  1 August 1986
Sodium and Water Excretion in Heart Failure: Efficacy of Treatment Has Surpassed Knowledge of Pathophysiology
GARY S. FRANCIS, M.D.
Ann Intern Med. 1986;105(2):272-274. doi:10.7326/0003-4819-105-2-272
Articles |  1 March 1986
Rapidly Developing Tolerance to Transdermal Nitroglycerin in Congestive Heart Failure
RANDY A. JORDAN, M.D.; LOVE SETH, M.D.; PENNY CASEBOLT, R.N.; et al.
Ann Intern Med. 1986;104(3):295-298. doi:10.7326/0003-4819-104-3-295
Articles |  1 February 1986
Influence of Renal Function on the Hemodynamic and Clinical Responses to Long-Term Captopril Therapy in Severe Chronic Heart Failure
MILTON PACKER, M. D.; WAI HUNG LEE, M.D.; NORMA MEDINA, R.N.; et al.
Ann Intern Med. 1986;104(2):147-154. doi:10.7326/0003-4819-104-2-147
Articles |  1 July 1985
Acute Vasoconstrictor Response to Intravenous Furosemide in Patients with Chronic Congestive Heart Failure: Activation of the Neurohumoral Axis
GARY S. FRANCIS, M.D.; ROBERT M. SIEGEL, M.D.; STEVEN R. GOLDSMITH, M.D.; et al.
Ann Intern Med. 1985;103(1):1-6. doi:10.7326/0003-4819-103-1-1
Articles |  1 March 1985
Furosemide Absorption Altered in Decompensated Congestive Heart Failure
MICHAEL R. VASKO, Ph.D.; DEBBIE BROWN-CARTWRIGHT, P.A.; JAMES P. KNOCHEL, M.D.; et al.
Ann Intern Med. 1985;102(3):314-318. doi:10.7326/0003-4819-102-3-314
Reviews |  1 September 1984
The Neurohumoral Axis in Congestive Heart Failure
GARY S. FRANCIS, M.D.; STEVEN R. GOLDSMITH, M.D.; T. BARRY LEVINE, M.D.; et al.
Ann Intern Med. 1984;101(3):370-377. doi:10.7326/0003-4819-101-3-370
Ideas and Opinions |  1 July 1984
Reevaluation of Digitalis Efficacy: New Light on an Old Leaf
CYNTHIA D. MULROW, M.D.; JOHN R. FEUSSNER, M.D.; RAMON VELEZ, M.D.
Ann Intern Med. 1984;101(1):113-117. doi:10.7326/0003-4819-101-1-113
Editorials |  1 June 1984
Sodium, Water, and Congestive Heart Failure
ROBERT W. HAMILTON, M.D.; VARDAMAN M. BUCKALEW, M.D.
Ann Intern Med. 1984;100(6):902-904. doi:10.7326/0003-4819-100-6-902
Articles |  1 January 1984
Endocardial Abnormalities in Left Ventricular Aneurysms: A Clinicopathologic Study
JUDITH S. HOCHMAN, M.D.; EDWARD B. PLATIA, M.D.; BERNADINE HEALY BULKLEY, M.D.
Ann Intern Med. 1984;100(1):29-35. doi:10.7326/0003-4819-100-1-29
Articles |  1 August 1982
Acute Effects of Alcohol in Patients with Congestive Heart Failure
BARRY H. GREENBERG, M.D.; RONALD SCHUTZ, M.D.; GARY L. GRUNKEMEIER, Ph.D; et al.
Ann Intern Med. 1982;97(2):171-175. doi:10.7326/0003-4819-97-2-171
Diagnosis and Treatment |  1 July 1982
Alpha-Adrenergic Receptor Blockade with Prazosin: Consideration of Hypertension, Heart Failure, and Potential New Applications
WILSON S. COLUCCI, M.D.
Ann Intern Med. 1982;97(1):67-77. doi:10.7326/0003-4819-97-1-67
Articles |  1 July 1981
Prazosin and Hydralazine in Congestive Heart Failure: Regional Hemodynamic Effects in Relation to Dose
RAYMOND D. MAGORIEN, M.D.; DOUGLAS W. TRIFFON, M.D.; CHRISTOPHER E. DESCH, M.D.; et al.
Ann Intern Med. 1981;95(1):5-13. doi:10.7326/0003-4819-95-1-5
Brief Reports |  1 September 1980
Increased Plasma Norepinephrine Levels During Prazosin Therapy for Severe Congestive Heart Failure
WILSON S. COLUCCI, M.D.; GORDON H. WILLIAMS, M.D.; EUGENE BRAUNWALD, M.D.
Ann Intern Med. 1980;93(3):452-453. doi:10.7326/0003-4819-93-3-452
Articles |  1 May 1980
Oral Hydralazine in Chronic Heart Failure: Sustained Beneficial Hemodynamic Effects
KANU CHATTERJEE, M. B.; THOMAS A. PORTS, M.D.; BRUCE H. BRUNDAGE, M.D.; et al.
Ann Intern Med. 1980;92(5):600-604. doi:10.7326/0003-4819-92-5-600
Articles |  1 November 1979
Risk Factors for Doxorubicin-lnduced Congestive Heart Failure
DANIEL D. VON HOFF, M.D.; MAXWELL W. LAYARD, Ph.D.; PETER BASA, B.S.; et al.
Ann Intern Med. 1979;91(5):710-717. doi:10.7326/0003-4819-91-5-710
Diagnosis and Treatment |  1 November 1979
Nitroprusside
JAY N. COHN, M.D.; LILLIAN P. BURKE, M.D.
Ann Intern Med. 1979;91(5):752-757. doi:10.7326/0003-4819-91-5-752
Articles |  1 September 1979
Attenuation of Prazosin Effect on Cardiac Output in Chronic Heart Failure
STEPHEN B. ARNOLD, M.D.; ROGER L. WILLIAMS, M.D.; THOMAS A. PORTS, M.D.; et al.
Ann Intern Med. 1979;91(3):345-349. doi:10.7326/0003-4819-91-3-345
Articles |  1 April 1977
Hemodynamic Improvement after Oral Hydralazine in Left Ventricular Failure: A Comparison with Nitroprusside Infusion in 16 Patients
JOSEPH A. FRANCIOSA, M.D., F.A.C.P.; GORDON PIERPONT, M.D., Ph.D.; JAY N. COHN, M.D., F.A.C.P.
Ann Intern Med. 1977;86(4):388-393. doi:10.7326/0003-4819-86-4-388
Articles |  1 February 1977
Chronic Congestive Heart Failure in Coronary Artery Disease: Clinical Criteria
WILLIAM R. HARLAN, M.D., F.A.C.P.; ALBERT OBERMAN, M.D., F.A.C.P.; RICHARD GRIMM, M.D.; et al.
Ann Intern Med. 1977;86(2):133-138. doi:10.7326/0003-4819-86-2-133
Advertisement

Buy This Article

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)